BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1725208)

  • 1. Sequential administration of interleukin-6 and granulocyte-colony stimulating factor in newborn rats: modulation of newborn granulopoiesis and thrombopoiesis.
    Cairo MS; Plunkett JM; Nguyen A; Clark S; van de Ven C
    Pediatr Res; 1991 Dec; 30(6):554-9. PubMed ID: 1725208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin-11 with and without granulocyte colony-stimulating factor on in vivo neonatal rat hematopoiesis: induction of neonatal thrombocytosis by interleukin-11 and synergistic enhancement of neutrophilia by interleukin-11 + granulocyte colony-stimulating factor.
    Cairo MS; Plunkett JM; Nguyen A; Schendel P; van de Ven C
    Pediatr Res; 1993 Jul; 34(1):56-61. PubMed ID: 7689197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined effects of interleukin-11, stem cell factor, and granulocyte colony-stimulating factor on newborn rat hematopoiesis: significant enhancement of the absolute neutrophil count.
    Cairo MS; Plunkett JM; Schendel P; van de Ven C
    Exp Hematol; 1994 Oct; 22(11):1118-23. PubMed ID: 7523164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of neonatal myelopoiesis in newborn rats after 7 days' administration of either granulocyte-monocyte colony stimulating factor or interleukin-3.
    Cairo MS; Mauss D; Plunkett JM; Gillis S; van de Ven C
    Pediatr Res; 1991 May; 29(5):504-9. PubMed ID: 1896256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of stem cell factor with and without granulocyte colony-stimulating factor on neonatal hematopoiesis: in vivo induction of newborn myelopoiesis and reduction of mortality during experimental group B streptococcal sepsis.
    Cairo MS; Plunkett JM; Nguyen A; van de Ven C
    Blood; 1992 Jul; 80(1):96-101. PubMed ID: 1377057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic effects of interleukin 6 and G-CSF in the later stage of human granulopoiesis in vitro.
    Katayama K; Koizumi S; Ueno Y; Ohno I; Ichihara T; Horita S; Miyawaki T; Taniguchi N
    Exp Hematol; 1990 Jun; 18(5):390-4. PubMed ID: 1692536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
    Bedford Russell AR; Davies EG; Gibson FM; Gordon-Smith EC
    Pediatr Res; 1995 May; 37(5):630-3. PubMed ID: 7541523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
    Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
    Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
    Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
    van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
    Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
    Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
    Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.
    Cairo MS; Mauss D; Kommareddy S; Norris K; van de Ven C; Modanlou H
    Pediatr Res; 1990 Jun; 27(6):612-6. PubMed ID: 1694023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term in vivo priming of bone marrow haematopoiesis with rhG-CSF, rhGM-CSF or rhIL-3 before marrow harvest expands myelopoiesis but does not improve engraftment capability.
    Hansen PB; Knudsen H; Gaarsdal E; Jensen L; Ralfkiaer E; Johnsen HE
    Bone Marrow Transplant; 1995 Sep; 16(3):373-9. PubMed ID: 8535309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
    Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
    Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven-day administration of recombinant human granulocyte colony-stimulating factor to newborn rats: modulation of neonatal neutrophilia, myelopoiesis, and group B Streptococcus sepsis.
    Cairo MS; Plunkett JM; Mauss D; Van de ven C
    Blood; 1990 Nov; 76(9):1788-94. PubMed ID: 1699622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
    Scheding S; Media JE; Nakeff A
    Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of neonatal rat myeloid kinetics resulting in peripheral neutrophilia by single pulse administration of Rh granulocyte-macrophage colony-stimulating factor and Rh granulocyte colony-stimulating factor.
    Cairo MS; van de Ven C; Mauss D; Kommareddy S; Norris K; Sheikh K; Modanlou H
    Biol Neonate; 1991; 59(1):13-21. PubMed ID: 1707685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo hematological effects of seven days of rhIL-6 in neonatal rats.
    Cairo MS; Plunkett JM; Clark S; van de Ven C
    Am J Pediatr Hematol Oncol; 1992; 14(1):44-7. PubMed ID: 1550262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.